Trial Profile
Personal dose monitoring of fluorouracil and metabolites of capecitabine(XELODA)in patients with colorectal cancer patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Pharmacokinetics
- Acronyms PersonaX
- 20 Sep 2018 Status changed from recruiting to completed.
- 11 Sep 2012 New trial record